decorative shape
patient advocacy strategies icon

Blog Post

Published April 14, 2026
Clinical Trial Recruitment

Barriers to Participation: What Families Face That Sponsors Don’t See

patient advocacy strategies logo

Clinical Research

Key Takeaways

  • Eligible patients often decline clinical trial participation due to various practical and emotional barriers, despite interest.
  • Logistical burdens, such as travel demands and complex schedules, significantly impact families’ decisions to participate.
  • Caregivers face emotional and financial challenges, further complicating the decision to enroll in trials.
  • Cultural and communication barriers affect patients’ trust, making participation less likely without proper representation.
  • Understanding the cumulative weight of these clinical trial participation barriers leads to more effective recruitment strategies.

Clinical Trial Participation Is About More Than Patient Interest

Why do eligible patients decline clinical trial participation even when they are interested in contributing to research?

For many sponsors, recruitment challenges are often viewed through the lens of awareness, site performance, or outreach effectiveness. However, participation decisions are rarely driven by awareness alone. Patients and caregivers frequently face practical and emotional realities that make participation difficult, even when they believe in the value of the study.

Families do not walk away from clinical trials because they lack interest. More often, they face obstacles that the protocol never fully anticipated.

Understanding those obstacles is one of the most important steps sponsors can take to improve both recruitment and retention.

The Gap Between Protocol Feasibility and Real-World Feasibility

A clinical trial may appear feasible on paper while feeling overwhelming to the families expected to participate.

Study teams often evaluate feasibility through operational metrics such as site capacity, visit schedules, enrollment targets, and protocol requirements. Patients and caregivers evaluate feasibility very differently.

They ask questions such as:

  • How much time will participation require?
  • Can we manage travel demands?
  • Will participation affect work, school, or caregiving responsibilities?
  • Do we fully understand what is being asked of us?
  • Can we realistically sustain participation for the duration of the study?

These considerations often determine whether a family chooses to participate long before they ever speak to a study coordinator.

The Hidden Impact of Logistical Burden

Logistical barriers are among the most common reasons families hesitate to participate.

Many studies require regular travel, extended site visits, frequent monitoring, or strict scheduling commitments. While these requirements may seem manageable during study planning, they can become significant challenges for participants.

Common logistical barriers include:

  • Long travel distances
  • Complex visit schedules
  • Time away from work
  • Missed school days
  • Transportation challenges
  • Limited childcare availability

Each challenge creates additional friction for patients and caregivers. When several occur simultaneously, participation can become unrealistic regardless of a patient’s interest in the study.

Caregiver and Emotional Burden Often Go Unrecognized

Participation decisions are not purely logistical.

Families managing chronic, rare, or complex conditions often carry significant emotional responsibilities long before research participation becomes an option.

Caregivers frequently balance medical appointments, treatment coordination, employment obligations, family responsibilities, and ongoing uncertainty about their loved one’s health. Adding a clinical trial may introduce additional stress, even when families recognize the potential benefits.

Emotional barriers may include:

  • Fear of the unknown
  • Concerns about safety or side effects
  • Caregiver burnout
  • Anxiety about study procedures
  • Uncertainty about expectations
  • Decision fatigue

These factors are difficult to measure but often play a major role in participation decisions.

Financial Challenges Can Influence Enrollment Decisions

Clinical trial participation may reduce treatment costs, but participation itself can create new financial pressures.

Travel expenses, lodging, meals, parking, childcare, and missed work can create burdens that families must carefully evaluate before enrolling.

For some patients, these expenses are manageable. For others, they become barriers that make participation impossible.

Sponsors that assess financial burden early can identify opportunities to reduce participation challenges through support programs, reimbursement strategies, or study design modifications.

Cultural and Communication Barriers Affect Trust

Not all participation barriers are operational.

Patients may hesitate when study materials feel difficult to understand, communication does not reflect their community, or previous healthcare experiences have created skepticism toward research participation.

Common challenges include:

  • Complex or highly technical language
  • Limited cultural relevance
  • Language accessibility issues
  • Lack of representation in materials
  • Historic mistrust of healthcare systems
  • Communication that feels one-sided or impersonal

When families do not feel understood or represented, trust becomes harder to establish. Without trust, participation becomes less likely.

Why Multiple Barriers Matter More Than Individual Barriers

Sponsors often focus on removing individual obstacles. However, participation decisions are typically influenced by the cumulative weight of several challenges occurring at the same time.

A family may be willing to travel.

A family may be able to manage a complicated schedule.

A family may have limited concerns about a study procedure.

But when travel demands, caregiver stress, financial burden, scheduling difficulties, and communication challenges occur simultaneously, participation becomes much harder to sustain.

The cumulative impact of these barriers frequently affects:

Understanding this cumulative burden is essential for building realistic and patient-centered studies.

Stronger Recruitment Starts with Understanding Patient Reality

The most effective recruitment strategies are built on a clear understanding of what patients and caregivers actually experience.

Sponsors that invest time in understanding participation barriers before recruitment begins are often better positioned to identify feasibility risks, reduce avoidable burden, and create a more accessible participant experience.

Rather than assuming why recruitment may struggle, these organizations seek direct insight into the real-world challenges that shape enrollment decisions.

This approach helps teams improve trial readiness, strengthen participant support strategies, and develop recruitment plans that align with the realities families face every day.

See Your Trial Through the Eyes of Patients and Caregivers

Recruitment and retention challenges often begin long before enrollment starts. PAS’s Clinical Trial Readiness Audit helps sponsors uncover hidden participation barriers, reduce patient burden, and strengthen study feasibility before launch. Build a trial experience that works for the people you’re asking to participate.

Josh Argall

About the Author
Josh is mission‑driven patient engagement and clinical trial recruitment leader with 20+ years of advocacy experience and deep expertise in rare disease communities. He specializes in building trust, strengthening sponsor–patient relationships, and designing engagement strategies that accelerate recruitment and improve retention.
Learn more about Josh Argall
patient advocacy strategies icon
search...